National Genetics Institute (NGI) gets go-ahead for hepatitis C test:
This article was originally published in Clinica
Executive Summary
The National Genetics Institute has FDA permission to sell its Superquant hepatitis C test to assess the antiviral effects of new drugs to treat the condition. The test has been used in large-scale studies of two new drugs. It is the first test to be able to claim that it directly measures the effects of an HCV treatment.